This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Glucagon
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | |||
<StructureSection load='1bh0' size='350' side='right' caption='Structure of human glucagon (PDB entry [[1bh0]])' scene=''> | <StructureSection load='1bh0' size='350' side='right' caption='Structure of human glucagon (PDB entry [[1bh0]])' scene=''> | ||
== Function == | == Function == | ||
| Line 13: | Line 12: | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
| - | [[ | + | [[1gcn]] - hGLC - human<br /> |
| - | + | ||
| - | + | ||
[[1bh0]] - hGLC (mutant)<br /> | [[1bh0]] - hGLC (mutant)<br /> | ||
| - | [[ | + | [[1kx6]], [[2m5p]], [[2m5q]], [[6nzn]] – hGLC - NMR<br /> |
| + | [[1nau]] – hGLC (mutant) – NMR<br /> | ||
| + | [[2g49]], [[6eds]] – hGLC preprotein residues 53-81+ insulin-degrading enzyme <br /> | ||
| + | |||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 10:25, 9 July 2019
| |||||||||||
3D Structures of glucagon
Updated on 09-July-2019
1gcn - hGLC - human
1bh0 - hGLC (mutant)
1kx6, 2m5p, 2m5q, 6nzn – hGLC - NMR
1nau – hGLC (mutant) – NMR
2g49, 6eds – hGLC preprotein residues 53-81+ insulin-degrading enzyme
References
- ↑ Ramnanan CJ, Edgerton DS, Kraft G, Cherrington AD. Physiologic action of glucagon on liver glucose metabolism. Diabetes Obes Metab. 2011 Oct;13 Suppl 1:118-25. doi:, 10.1111/j.1463-1326.2011.01454.x. PMID:21824265 doi:http://dx.doi.org/10.1111/j.1463-1326.2011.01454.x
- ↑ Heptulla RA, Rodriguez LM, Bomgaars L, Haymond MW. The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes. Diabetes. 2005 Apr;54(4):1100-7. PMID:15793249

